Kolinpharma (KIP.MI) Competitor Comparison
We are evaluating the key criteria listed to compare Kolinpharma (KIP.MI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
48 / 54Gross Profits
38 / 39Total Revenue
47 / 50EBITDA
31 / 53Free Cashflow
29 / 54Quick Ratio
14 / 54Earnings per Share
18 / 54Dividend yield
0 / 5Total Cash
47 / 54Performance 3 years
11 / 54Performance 5 years
9 / 54Performance 10 years
10 / 54Linearity 3 years
3 / 54Linearity 5 years
17 / 54Linearity 10 years
16 / 54Total Rank
20 / 54Dividend Rank
26 / 54Valuation Rank
23 / 54Piotroski Rank
5 / 54Muliplier Rank
47 / 54Gross Profits - KIP.MI ranking 38 / 39
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.